Mu?oz-Mart?nez S, Sapena V, Forner A, Nault JC, Sapisochin G, Rimassa L, Sangro B, Bruix J, Sanduzzi-Zamparelli M, Hol?wko W, El Kassas M, Mocan T, Bouattour M, Merle P, Hoogwater FJH, Alqahtani SA, Reeves HL, Pinato DJ, Giorgakis E, Meyer T, Villadsen GE, Wege H, Salati M, M?nguez B, Di Costanzo GG, Roderburg C, Tacke F, Varela M, Galle PR, Alvares-da-Silva MR, Trojan J, Bridgewater J, Cabibbo G, Toso C, Lachenmayer A, Casadei-Gardini A, Toyoda H, L?dde T, Villani R, Matilla Pe?a AM, Guedes Leal CR, Ronzoni M, Delgado M, Perell? C, Pascual S, Lled? JL, Argemi J, Basu B, da Fonseca L, Acevedo J, Siebenh?ner AR, Braconi C, Meyers BM, Granito A, Sala M, Rodr?guez-Lope C, Blaise L, Romero-G?mez M, Pi?ero F, Gomez D, Mello V, Pinheiro Alves RC, Fran?a A, Branco F, Brandi G, Pereira G, Coll S, Guarino M, Ben?tez C, Anders MM, Bandi JC, Vergara M, Calvo M, Peck-Radosavljevic M, Garc?a-Ju?rez I, Cardinale V, Lozano M, Gambato M, Okolicsanyi S, Morales-Arraez D, Elvevi A, Mu?oz AE, Lu? A, Iavarone M, Reig M. Assessing the impact of COVID-19 on liver cancer management (CERO-19). JHEP Rep. 2021 Jun; 3(3):100260.